Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CTVA
CTVA logo

CTVA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Corteva Inc (CTVA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
78.590
1 Day change
1.58%
52 Week Range
85.630
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Corteva Inc (CTVA) is not a strong buy at this moment for a beginner investor with a long-term focus. While the stock has positive growth potential and some favorable analyst ratings, the recent restructuring costs, financial burdens, and cautious trading sentiment from Congress members suggest a wait-and-see approach might be more prudent. The SwingMax signal indicates a recent entry opportunity, but the stock's long-term prospects are clouded by financial and operational challenges.

Technical Analysis

The MACD is positive and expanding, suggesting bullish momentum. RSI is neutral at 69.952, and moving averages are converging, indicating no strong trend. The stock is trading near resistance levels (R1: 78.322, R2: 79.415), which could limit immediate upside potential.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
8

Positive Catalysts

  • Analysts have raised price targets, with several maintaining Buy or Overweight ratings.

  • Strategic supply agreement with FMC to enhance market presence in corn and soybean markets.

  • SwingMax signal indicates a recent entry opportunity.

Neutral/Negative Catalysts

  • Significant restructuring costs ($750M-$815M) and cash outflows ($400M-$443M) impacting liquidity.

  • Financial burden from a class action settlement of $85M.

  • Congress trading data shows more selling than buying, indicating cautious sentiment.

  • European market share may be affected due to production cessation at the Asturias site.

Financial Performance

Financial data unavailable for analysis, but recent news highlights increased restructuring costs and financial outflows, which could strain the company's balance sheet.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are generally positive on Corteva, with price targets ranging from $83 to $95. Recent upgrades reflect optimism about growth and stabilization trends, but some analysts maintain Neutral ratings, citing geopolitical and cost pressures.

Wall Street analysts forecast CTVA stock price to rise
13 Analyst Rating
Wall Street analysts forecast CTVA stock price to rise
9 Buy
4 Hold
0 Sell
Moderate Buy
Current: 77.370
sliders
Low
77
Averages
83.75
High
89
Current: 77.370
sliders
Low
77
Averages
83.75
High
89
Morgan Stanley
Vincent Andrews
maintain
$84 -> $95
AI Analysis
2026-05-28
Reason
Morgan Stanley
Vincent Andrews
Price Target
$84 -> $95
AI Analysis
2026-05-28
maintain
Reason
Morgan Stanley analyst Vincent Andrews raised the firm's price target on Corteva to $95 from $84 and keeps an Overweight rating on the shares. The market is valuing "New Corteva" like a no-growth commodity chemical maker, which is "too bearish" as the investment debate shifts to New Corteva's standalone growth rate, the analyst tells investors.
UBS
Joshua Spector
Neutral
maintain
$88 -> $90
2026-05-07
Reason
UBS
Joshua Spector
Price Target
$88 -> $90
2026-05-07
maintain
Neutral
Reason
UBS analyst Joshua Spector raised the firm's price target on Corteva to $90 from $88 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CTVA
Unlock Now

People Also Watch